AzTrials
AzTrials

Shoulder InjuryChirépauleNCT06808269

Prospective Comparative Multicenter Study of the Care Pathway After Shoulder Surgery

A study testing Vivalto Dom follow-up and Liberal follow-up in people with Shoulder Injury, run by Clinique Victor Hugo at 2 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Post-operative management of shoulder surgery patients, particularly in terms of pain management and follow-up, can vary from one center to another, influencing clinical outcomes and patient satisfaction. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shoulder Injury
What is being tested?
Vivalto Dom follow-up and Liberal follow-up
Could I receive a placebo?
No, everyone receives an active treatment
How many people
210 participants
Where
2 sitesFrance
Study dates
19 May 2025to 31 Aug 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient eligible for one of the following 4 types of surgery: Simple non-repair arthroscopic surgery (acromion, calcification), arthroscopic repair surgery (cuff, DAS, bankart), open surgery without prosthesis (ligamentoplasty, bone block), open surgery with prosthesis (inverted prosthesis, anatomic prosthesis, etc.).

Who cannot join

  • Patients with one or more communication disorders.
  • Pregnant or breast-feeding patients
  • Patients not covered by a social security scheme
  • Refusal to participate in research
  • Patients unable to understand or give informed consent
  • Patients under guardianship, deprived of liberty or under court protection
Show all 10Show fewer
  • Patients with past or present drug addiction
  • Patients with neuropathy
  • Patients with cognitive disorders
  • Patients with chronic illnesses or inflammatory pathologies leading to chronic pain.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Philippe Collin, MD contact

+33 6 08 91 47 47

docphcollin@gmail.com

France2 sites, 2 recruiting
  • Clinique Victor Hugo

    Paris, 75116

    Marion Mandon, PhD, +33678 27 76 72, mmandon@vivalto-sante.com

    Recruiting
  • Centre hospitalier privé Saint-Grégoire

    Saint-Grégoire, 35760

    Marion Mandon, PhD, +33678 27 76 72, mmandon@vivalto-sante.com

    Recruiting

Other trials in France

About this study

Post-operative management of shoulder surgery patients, particularly in terms of pain management and follow-up, can vary from one center to another, influencing clinical outcomes and patient satisfaction. The aim of this study is to compare two approaches to post-operative follow-up in two distinct centers: structured follow-up using the Vivalto-Dom protocol in Paris, and autonomous follow-up through contact with a nurse in Saint-Grégoire. The hypothesis is that these differences in the care pathway will affect pain management, comfort and patient satisfaction. By controlling for operative variability (a single surgeon operating in both centers), the study will identify the most effective follow-up practices for improving post-operative management, with the ultimate aim of optimizing quality of care and reducing post-operative complications.

Conditions
Shoulder Injury
Being tested
Vivalto Dom follow-up, Liberal follow-up
Keywords
shoulder surgery, pain, comfort
Medical subject headings
Shoulder Injuries, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vivalto Dom follow-upProcedure or surgery

    During the pre-operative consultation, the patient receives a prescription for medication (analgesics and anti-inflammatories) for immediate post-operative pain relief. They also receive a "patient information booklet" (see appendix 6). On discharge from surgery, the patient returns home with Vivalto Dom in charge of nursing care and follow-up medication.

    Vivalto Dom is a homecare structure whose mission is to coordinate the discharge of patients back home, and to ensure continuity of overall care (care and social aspects) between the hospital and the city.

  • Liberal follow-upProcedure or surgery

    The pre-operative and operative course (fasting rules, skin preparation, hospitalization, surgery) is the same as for all routine care patients. The patient is informed before surgery that he or she must make an appointment with a nurse for post-operative care at home; a prescription for medication (analgesics and anti-inflammatories) has been given by the anaesthetist for immediate analgesic treatment, and on discharge from hospital he or she receives another prescription from the surgeon for oral relay treatment.

    Follow-up at home takes place over 3 days, with a private nurse visiting the patient's home every day.

    During the follow-up, the nurse performs clinical monitoring of the following items: pulse, blood pressure, temperature, pain, bleeding, monitoring of the surgical wound, transit, nausea and vomiting. The patient is also guided through the medication protocol.

Study groups in NCT06808269
Study groupRoleWhat they receive
structured follow-up after surgeryExperimentalNot described
Receives: Procedure: Vivalto Dom follow-up
liberal follow-up after surgeryActive comparatorNot described
Receives: Procedure: Liberal follow-up

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity (VAS)

    Pain will be measured using VAS (visual analog scale), from 0 ("no pain") to 10 (maximal pain)

    Measured: 3 days, 6 weeks, 3 months and 6 months after surgery

Secondary outcomes (2)
  1. Patient comfort (Likert scale)

    Patient comfort will be evaluated using a Likert scale for 6 questions. Scale is from 1 (total discomfort) to 5 (total comfort)

    Measured: 3 days, 6 weeks, 3 months and 6 months after surgery

  2. Postoperative complications

    Measured: 3 days, 6 weeks, 3 months and 6 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2025
  2. Study start19 May 2025
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion31 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
210 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06808269
Sponsor's protocol ID
2024-28-CVH
Other IDs
2024-A02076-41
Acronym
Chirépaule
Status last verified
Sep 2026
First submitted
28 Jan 2025
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Vivalto Dom follow-up and Liberal follow-up in people with Shoulder Injury, run by Clinique Victor Hugo at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Philippe Collin, MD (+33 6 08 91 47 47, docphcollin@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (VAS) (time frame: 3 days, 6 weeks, 3 months and 6 months after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in